Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Pulmonary manifestations of liver diseases.

Yeshua H, Blendis LM, Oren R.

Semin Cardiothorac Vasc Anesth. 2009 Mar;13(1):60-9. doi: 10.1177/1089253209334615. Epub 2009 Mar 31. Review.

PMID:
19336439
2.

Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

Fishman S, Lurie Y, Peretz H, Morad T, Grynberg E, Blendis LM, Leshno M, Brazowski E, Rosner G, Halpern Z, Oren R.

Liver Int. 2006 Apr;26(3):279-84.

PMID:
16584388
3.

Effect of interferon, ribavirin and ursodeoxycholic acid in patients with hepatitis C infection.

Ljubuncic P, Konikoff FM, Blendis LM, Bomzon A.

Hepatogastroenterology. 2005 Jul-Aug;52(64):1191-6.

PMID:
16001659
4.

Does losartan work after all?

Blendis LM, Wong F.

Am J Gastroenterol. 2003 Jun;98(6):1222-4. No abstract available.

PMID:
12818261
6.

An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis.

Neuman MG, Cameron RG, Haber JA, Katz GG, Blendis LM.

Liver. 2002 Jun;22(3):235-44.

PMID:
12100574
7.

Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?

Wong F, Siu S, Liu P, Blendis LM.

Clin Sci (Lond). 2001 Dec;101(6):621-8.

PMID:
11724649
8.

Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites.

Allard JP, Chau J, Sandokji K, Blendis LM, Wong F.

Am J Gastroenterol. 2001 Aug;96(8):2442-7.

PMID:
11513188
9.

Accumulation of macrophages in primary sclerosing cholangitis.

Cameron RG, Blendis LM, Neuman MG.

Clin Biochem. 2001 May;34(3):195-201.

PMID:
11408017
10.

Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate.

Neuman MG, Blendis LM, Shear NH, Malkiewicz IM, Ibrahim A, Katz GG, Sapir D, Halpern Z, Brill S, Peretz H, Magazinik S, Konikoff FM.

Clin Biochem. 2001 May;34(3):183-8.

PMID:
11408015
11.

Portal hypertension induces sodium channel expression in colonocytes from the distal colon of the rat.

Fraser GM, Blendis LM, Smirnoff P, Sikular E, Niv Y, Schwartz B.

Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G886-92.

12.

The effects of hypothyroidism on liver status of cirrhotic patients.

Oren R, Sikuler E, Wong F, Blendis LM, Halpern Z.

J Clin Gastroenterol. 2000 Sep;31(2):162-3.

PMID:
10993436
13.

Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?

Gentilini P, Laffi G, La Villa G, Romanelli RG, Blendis LM.

J Hepatol. 1999 Dec;31(6):1088-97. Review. No abstract available.

PMID:
10604585
14.

A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis.

Baruch Y, Assy N, Weisbruch F, Reisner SA, Rinkevich D, Enat R, Blendis LM, Bomzon A.

Am J Gastroenterol. 1999 Oct;94(10):3000-4.

PMID:
10520859
15.

Multivesicular stellate cells in primary biliary cirrhosis.

Cameron RG, Neuman MG, Shear N, Blendis LM.

Hepatology. 1997 Oct;26(4):819-22.

PMID:
9328298
16.

Multivesicular stellate cells in primary biliary cirrhosis.

Cameron RG, Neuman MG, Shear NH, Blendis LM.

Hepatology. 1997 Sep;26(3):550-3. Erratum in: Hepatology 1997 Nov;26(5):1370.

PMID:
9303481
17.

Experimental study in bile duct-ligated rats of vasopressin and preoperative volume loading to prevent hypotensive crises.

Jacob G, Zuk R, Blendis LM, Eitan A, Bomzon A.

Br J Surg. 1997 Apr;84(4):483-7.

PMID:
9112897
18.

Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.

Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.

Am J Gastroenterol. 1997 Mar;92(3):394-9.

PMID:
9068457
19.

Evaluation of liver transplantation for high-risk indications.

Chung SW, Greig PD, Cattral MS, Taylor BR, Sheiner PA, Wanless I, Cameron R, Phillips MJ, Blendis LM, Langer B, Levy GA.

Br J Surg. 1997 Feb;84(2):189-95.

PMID:
9052430
20.

The patient with renal insufficiency.

Wong F, Blendis LM.

Liver Transpl Surg. 1996 Sep;2(5 Suppl 1):35-43. Review. No abstract available.

21.
22.

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ.

Hepatology. 1996 May;23(5):1148-53.

PMID:
8621147
23.

Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis.

Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L, et al.

Hepatology. 1995 Nov;22(5):1415-22.

PMID:
7590657
24.

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.

Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, Shouval D, Galun E.

Cancer. 1995 May 15;75(10):2420-6.

PMID:
7736384
25.

Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.

Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G.

Hepatology. 1995 May;21(5):1238-47.

PMID:
7737629
26.

Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blendis LM, Cameron RG, McClelland RA, Liu PP, Templeton DM, Koren G.

N Engl J Med. 1995 Apr 6;332(14):918-22.

27.

Effect of insulin on the venoconstrictive response to norepinephrine in normal human subjects: the influence of sodium status.

Wong FS, Miller JA, Blendis LM, Logan AG.

Am J Hypertens. 1994 Dec;7(12):1097-104.

PMID:
7702805
28.

The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis.

Bomzon A, Blendis LM.

Hepatology. 1994 Nov;20(5):1343-50. Review. No abstract available.

PMID:
7927270
29.

Effect of acute lactulose administration on serum acetate levels in cirrhosis.

Fernandes J, Morali G, Wolever TM, Blendis LM, Koo M, Jenkins DJ, Rao AV.

Clin Invest Med. 1994 Jun;17(3):218-25.

PMID:
7923999
30.

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, et al.

Hepatology. 1994 May;19(5):1149-56.

PMID:
8175136
31.
32.

The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators.

Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, Greig PD, Levy G, Blendis LM.

Hepatology. 1993 Dec;18(6):1370-6.

PMID:
8244261
33.

Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.

Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.

Hepatology. 1993 Sep;18(3):519-28.

PMID:
8395457
34.

Peritoneovenous shunting restores atrial natriuretic factor responsiveness in refractory hepatic ascites.

Tobe SW, Morali GA, Greig PD, Logan A, Blendis LM.

Gastroenterology. 1993 Jul;105(1):202-7.

PMID:
8514035
35.

Angiotensin II modulates atrial natriuretic factor-induced natriuresis in cirrhosis with ascites.

Tobe SW, Blendis LM, Morali GA, Warner LC, Logan AG, Skorecki KL.

Am J Kidney Dis. 1993 May;21(5):472-9.

PMID:
8488814
36.

Circulation in liver disease.

Blendis LM.

Transplant Proc. 1993 Apr;25(2):1741-3. Review. No abstract available.

PMID:
8470148
37.

Atrial natriuretic factor and liver disease.

Warner L, Skorecki K, Blendis LM, Epstein M.

Hepatology. 1993 Mar;17(3):500-13. Review. Erratum in: Hepatology 1993 Jun;17(6):1174.

PMID:
8444424
38.

Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion.

Legault L, Warner LC, Leung WM, Logan AG, Blendis LM, Skorecki KL.

Can J Physiol Pharmacol. 1993 Feb;71(2):157-64.

PMID:
8319139
40.

Review article: the treatment of alcoholic liver disease.

Blendis LM.

Aliment Pharmacol Ther. 1992 Oct;6(5):541-8. Review.

PMID:
1420746
41.

Hepatology elsewhere: twenty years after!

Blendis LM.

Hepatology. 1992 Oct;16(4):1096-8. No abstract available.

PMID:
1398493
42.

Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?

Morali GA, Sniderman KW, Deitel KM, Tobe S, Witt-Sullivan H, Simon M, Heathcote J, Blendis LM.

J Hepatol. 1992 Sep;16(1-2):249-50. No abstract available.

PMID:
1484164
43.

Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.

Morali GA, Tobe SW, Skorecki KL, Blendis LM.

Hepatology. 1992 Jul;16(1):42-8.

PMID:
1535608
44.

Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.

Phillips MJ, Cameron R, Flowers MA, Blendis LM, Greig PD, Wanless I, Sherman M, Superina R, Langer B, Levy GA.

Am J Pathol. 1992 Jun;140(6):1295-308.

45.

Hepatocyte swelling and portal hypertension.

Blendis LM.

J Hepatol. 1992 May;15(1-2):4-5. Review. No abstract available.

PMID:
1506655
46.

Clonidine for portal hypertension: a sympathetic solution?

Blendis LM.

Ann Intern Med. 1992 Mar 15;116(6):515-7. No abstract available.

PMID:
1739244
47.

Pressor response to a postural change in cirrhosis: an experimental study in the CCl4-treated rat.

Bomzon A, Weinbroum A, Blendis LM.

Clin Sci (Lond). 1992 Feb;82(2):147-56.

PMID:
1311652
48.

The influence of propanolol on portosystemic shunting.

Blendis LM.

Hepatology. 1991 Nov;14(5):952-3. No abstract available.

49.

Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.

Morali GA, Floras JS, Legault L, Tobe S, Skorecki KL, Blendis LM.

Am J Med. 1991 Oct;91(4):383-92.

PMID:
1835288
50.

Aldosterone, atrial natriuretic factor and sodium intake as determinants of the natriuretic response to head-out water immersion in healthy subjects.

Warner LC, Morali GA, Miller JA, Logan AG, Skorecki KL, Blendis LM.

Clin Sci (Lond). 1991 May;80(5):475-80.

PMID:
1851688

Supplemental Content

Loading ...
Support Center